StreetInsider.com News Articles

Form 8-K CorMedix Inc. For: Aug 07

Fri, 07 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260807/26891331.html

Form 8-K CorMedix Inc. For: Aug 07

Fri, 07 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260807/26891331.html

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Wed, 29 Jul 2026 08:30:00 -0400

PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026, and will host a corporate update conference call at 8:30am Eastern Time.

*Thursday, August 13*th @ 8:30am ET
Domestic:	1-844-676-2922
International:	1-412-634-6840
Webcast:	Webcast Link

About CorMedix
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Wed, 29 Jul 2026 08:30:00 -0400

*Thursday, August 13*th @ 8:30am ET
Domestic:	1-844-676-2922
International:	1-412-634-6840
Webcast:	Webcast Link

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Wed, 29 Jul 2026 08:30:00 -0400

*Thursday, August 13*th @ 8:30am ET
Domestic:	1-844-676-2922
International:	1-412-634-6840
Webcast:	Webcast Link

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Wed, 29 Jul 2026 08:30:00 -0400

*Thursday, August 13*th @ 8:30am ET
Domestic:	1-844-676-2922
International:	1-412-634-6840
Webcast:	Webcast Link

CorMedix (CRMD) PT Lowered to $13 at RBC Capital

Tue, 07 Jul 2026 07:59:56 -0400

RBC Capital analyst Leonid Timashev lowered the price target on CorMedix (NASDAQ: CRMD) to $13.00 (from $14.00) while maintaining a Outperform rating.

Form 8-K CorMedix Inc. For: Jun 29

Thu, 02 Jul 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260702/26728441.html

Form 8-K CorMedix Inc. For: Jun 29

Thu, 02 Jul 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260702/26728441.html

Form 8-K CorMedix Inc. For: Jun 25

Wed, 01 Jul 2026 07:14:00 -0400

si-local-file:///var/storage/secattach/20260701/26716754.html

Form 8-K CorMedix Inc. For: Jun 25

Wed, 01 Jul 2026 07:14:00 -0400

si-local-file:///var/storage/secattach/20260701/26716754.html

Form S-8 POS CorMedix Inc.

Thu, 25 Jun 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260625/26692901.html

Form S-8 POS CorMedix Inc.

Thu, 25 Jun 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260625/26692901.html

Form 8-K CorMedix Inc. For: Jun 23

Wed, 24 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260624/26685958.html

Form 8-K CorMedix Inc. For: Jun 23

Wed, 24 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260624/26685958.html

Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER

Fri, 12 Jun 2026 13:24:00 -0400

si-local-file:///var/storage/secattach/20260612/26639909.html

Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER

Fri, 12 Jun 2026 13:24:00 -0400

si-local-file:///var/storage/secattach/20260612/26639909.html

Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER

Fri, 12 Jun 2026 13:07:00 -0400

si-local-file:///var/storage/secattach/20260612/26639857.html

Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER

Fri, 12 Jun 2026 13:07:00 -0400

si-local-file:///var/storage/secattach/20260612/26639857.html

Form 8-K CorMedix Inc. For: Jun 08

Mon, 08 Jun 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260608/26614889.html

Form 8-K CorMedix Inc. For: Jun 08

Mon, 08 Jun 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260608/26614889.html

CorMedix wins federal appeals court ruling on Minocin patent case

Mon, 08 Jun 2026 08:32:40 -0400

The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling that upholds CorMedix Therapeutics' (NASDAQ: CRMD) patents for Minocin for Injection and finds Nexus Pharmaceuticals infringed those patents.

The Federal Circuit decision upheld a 2023 district court ruling from the U.S. District Court for the Northern District of Illinois following a four-day bench trial. The lower court had found in favor of CorMedix's subsidiary Melinta Therapeutics on patent infringement and validity issues.

The appeals court rejected Nexus Pharmaceuticals' challenge to the patent validity and affirmed a permanent injunction preventing Nexus from marketing its generic minocycline product before the

CorMedix wins federal appeals court ruling on Minocin patent case

Mon, 08 Jun 2026 08:32:40 -0400

The appeals court rejected Nexus Pharmaceuticals' challenge to the patent validity and affirmed a permanent injunction preventing Nexus from marketing its generic minocycline product before the

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Mon, 08 Jun 2026 08:30:00 -0400

PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.

Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Mon, 08 Jun 2026 08:30:00 -0400